5
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Urinary Cyclic Adenosine Monophosphate Excretion in Diabetes Insipidus of Childhood Effect of Vasopressin and Chlorpropamide

, &
Pages 177-184 | Received 01 Dec 1973, Accepted 23 Apr 1974, Published online: 28 Aug 2009

References

  • Avery S., Clark C. M., Trygstad C., Bell N. H. Effects of cyclic adenosine monophosphate (AMP) and dibutyryl cyclic AMP in antidiuretic hormone‐deficient and antidiuretic hormone‐resistant diabetes insipidus. J. clin. Invest. 1971; 50: 3a
  • Bär H. ‐P., Hechter O., Schwartz I. L., Walter R. Neurohypophyseal hormone‐sensitive adenyl cyclase of toad urinary bladder. Proc. nat. Acad. Sci. (Wash.) 1970; 67: 7
  • Bell N. H., Clark C. M., Jr., Avery S., Sinha T., Trygstadt C., Allen D. O. Demonstration of defects in the formation of and response to cyclic 3′,5′‐adenosine monophosphate in vasopressin‐resistant diabetes insipidus. Clin. Res. 1971; 19: 685
  • Broadus A. E., Kaminsky N. I., Hardman J. G., Sutherland E. W., Liddle G. W. Kinetic parameters and renal clearances of plasma adenosine 3′,5′‐monophosphate and guanosine 3′,5′‐monophosphate in man. J. clin. Invest. 1970; 49: 2222
  • Brown E., Clarke D. L., Roux V., Sherman G. H. The stimulation of adenosine 3′,5′‐mono‐phosphate production by antidiuretic factors. J. biol. Chem. 1963; 238: 852
  • Chase L. R., Aurbach G. D. Parathyroid function and the renal excretion of 3′,5′‐adenylic acid. Proc. nat. Acad. Sci. (Wash.) 1967; 58: 518
  • Chase L. R., Aurbach G. D. Renal adenyl cyclase; anatomically separate sites for parathyroid hormone and vasopressin. Science 1968; 159: 545
  • Chase L. R., Melson G. L., Aurbach G. D. Pseudohypoparathyroidism: defective excretion of 3′,5′‐AMP in response to parathyroid hormone. J. clin. Invest. 1969; 48: 1832
  • Davis B., Zor U., Kaneko T., Mintz D. H. Effects of parathyroid extract (PTE). arginine vasopressin (AVP) and prostaglandin E1 (PGE1) on urinary and renal tissue cyclic 3′5′adenosine monophosphate (CAMP). Clin. Res. 1969; 17: 458
  • Dousa T., Hechter O., Walter R., Schwartz I. L. Effects of neurohypophyseal hormones (NHH) and analogs on renal medullary adenyl cyclase (RMAC). Physiologist 1970; 13: 182
  • Dousa T., Hechter O., Schwartz I. L., Walter R. Neurohypophyseal hormone‐responsive adenylate cyclase from mammalian kidney. Proc. nat. Acad. Sci. (Wash.) 1971; 68: 1693
  • Dousa T. P., Walter R., Schwartz I. L., Sands H., Hechter O. Role of cyclic AMP in the action of neurohypophyseal hormones on kidney. Advances in Cyclic Nucleotide Research, P. Greengard, R. Paoletti, G. A. Robison. Raven Press, New York 1972; Vol. 1: 121–135
  • Fichman M. P., Brooker G. Deficient renal cyclic adenosine 3′‐5′monophosphate production in nephrogenic diabetes insipidus. J. clin. Endocr. 1972; 35: 35
  • Grantham J. J., Burg M. B. Effect of vasopressin and cyclic AMP on permeability of isolated collecting tubules. Amer. J. Physiol. 1966; 211: 255
  • Handler J. S., Butcher R. W., Sutherland E. W., Orloff J. The effect of vasopressin and theophylline on the concentration of adenosine 3′,5′‐phosphate in the urinary bladder of the toad. J. biol. Chem. 1965; 240: 4524
  • Hardman J. G., Davis J. W., Sutherland E. W. Effects of some hormonal and other factors on the excretion of guanosine 3′,5′‐monophosphate and adenosine 3′,5′‐monophos‐phate in rat urine. J. biol. Chem. 1969; 244: 6354
  • Hardman J. G. Cyclic GMP and cyclic AMP in urine. Cyclic AMP. Academic Press, New York and London 1971; 413–419
  • De Jonge H. Inleiding tot de Medische Statistiek. Deel II2nd ed. Verhandeling van het Nederlands Instituut voor Praeventieve Geneeskunde, Leiden 1964; 486–487
  • Kaminsky N. I., Ball J. H., Broadus A. E., Hardman J. G., Sutherland E. W., Liddle G. W. Hormonal effects on extracellular cyclic nucleotides in man. Trans. Ass. Amer. Phycns. 1970; 83: 235
  • Kingsley G. R., Schaffert R. R. Standard Methods in Clinical Chemistry, M. Reiner. Academic Press, New York 1953; 55
  • Leaf A., Hays R. M. Permeability of the isolated toad bladder to solutes and its modification by vasopressin. J. gen. Physiol. 1962; 45: 921
  • Levine R. A. Antidiuretic responses to exogenous adenosine 3′,5′‐monophosphate in man. Clin. Sci. 1968; 34: 253
  • Maxwell M. H., Breed E. S. The effect of the intravenous administration of Pitressin on renal function in man. J. Pharmacol. exp. Ther. 1951; 103: 190
  • Orloff J., Handler J. S. The similarity of effects of vasopressin, adenosine 3′,5′‐phosphate (cyclic AMP) and theophylline on the toad bladder. J. clin. Invest. 1962; 41: 702
  • Orloff J., Handler J. The role of adenosine 3′,5′‐phosphate in the action of antidiuretic hormone. Amer. J. Med. 1967; 42: 757
  • Raij K., Harkonen M., Adlercreutz H. A. Simplified method for the determination of cyclic AMP in urine and tissues. Scand. J. clin. Lab. Invest. 1971; 27(Suppl. 116)
  • Raij K., Härkönen M., Castrén O., Saarikoski S., Adlercreutz H. Cyclic AMP excretion in toxaemia of pregnancy. Scand. J. clin. Lab. Invest. 1973; 32: 193
  • Richterich R. Klinische Chemie. Theorie und Praxis. S. Karger, Basel and New York 1968; 17–36
  • Takahashi K., Kamimura M., Shinko T., Tsuji S. Effects of vasopressin and water‐load on urinary adenosine‐3′,5′‐cyclic monophosphate. Lancet 1966; 29: 967
  • Taylor A. L., Davis B. B., Pawlson L. G., Josimovich J. B., Mintz D. H. Factors influencing the urinary excretion of 3′,5′‐adenosine monophosphate in humans. J. clin. Endocr. 1970; 30: 316
  • Wesson L. G. Physiology of the Human Kidney. Grune & Stratton, New York 1969; 634
  • Williams R. H., Barish J., Ensinck J. W. Hormone effects upon cyclic nucleotide excretion in man. Proc. Soc. exp. Biol. (N.Y.) 1972; 139: 447

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.